Search results
Jump to navigation
Jump to search
Page title matches
- ==Anatomy of a platelet== ...brand factor]]), the contents of which are released upon activation of the platelet. These granule contents play an important role in both [[hemostasis]] and i12 KB (1,658 words) - 08:52, 28 June 2011
- #Redirect [[Platelet activation]]33 bytes (3 words) - 23:51, 29 April 2008
- 12 bytes (1 word) - 09:26, 13 November 2007
- 76 bytes (9 words) - 17:41, 22 June 2008
- ..."series of progressive, overlapping events, triggered by exposure of the [[platelet]]s to subendothelial tissue. These events include shape change, adhesivenes Platelet activation, along with [[coagulation]], leads to [[hemostasis]].573 bytes (73 words) - 03:16, 7 October 2013
- #redirect [[Platelet aggregation inhibitors]]45 bytes (4 words) - 09:48, 29 April 2008
- #REDIRECT [[Platelet aggregation inhibitors]]45 bytes (4 words) - 08:13, 23 November 2010
- #Redirect [[Platelet aggregation inhibitors]]45 bytes (4 words) - 23:50, 29 April 2008
- Auto-populated based on [[Special:WhatLinksHere/Platelet]]. Needs checking by a human. {{r|Platelet activation}}955 bytes (116 words) - 19:35, 11 January 2010
- 166 bytes (20 words) - 09:34, 8 September 2009
- ...antagonize or impair any mechanism leading to blood [[platelet activation|platelet aggregation]], whether during the phases of activation and shape change or Inhibitors of the [[platelet glycoprotein GPIIb-IIIa complex]] (GPIs) include the [[monoclonal antibody]4 KB (543 words) - 01:43, 8 May 2013
- {{r|Platelet aggregation inhibitors|Platelet aggregation inhibitor}}215 bytes (22 words) - 17:24, 27 August 2008
- Agents that antagonize or impair any mechanism leading to blood platelet aggregation.122 bytes (15 words) - 09:35, 8 September 2009
- {{r|Platelet activation}}151 bytes (16 words) - 17:22, 27 August 2008
- .../cgi/mesh/2008/MB_cgi?term=Platelet+Glycoprotein+GPIIb-IIIa+Complex |title=Platelet Glycoprotein GPIIb-IIIa Complex |accessdate=2008-01-10 |author=Anonymous |a ...irofiban]], block the platelet glycoprotein GPIIb-IIIa complex and inhibit platelet aggregation. They arp used to treat [[vascular disease]]s.2 KB (291 words) - 21:55, 14 February 2010
- #REDIRECT [[Platelet glycoprotein GPIIb-IIIa complex]]54 bytes (5 words) - 08:28, 11 January 2008
- 12 bytes (1 word) - 21:41, 22 January 2008
- Integrin receptor found on platelets for fibrinogen, and aids in platelet activation.122 bytes (15 words) - 09:37, 8 September 2009
- Auto-populated based on [[Special:WhatLinksHere/Platelet glycoprotein GPIIb-IIIa complex]]. Needs checking by a human. {{r|Platelet aggregation inhibitors}}562 bytes (68 words) - 19:35, 11 January 2010
Page text matches
- *[[Platelet activation]] **[[Platelet aggregation inhibitor]]157 bytes (11 words) - 04:36, 10 June 2008
- ..."series of progressive, overlapping events, triggered by exposure of the [[platelet]]s to subendothelial tissue. These events include shape change, adhesivenes Platelet activation, along with [[coagulation]], leads to [[hemostasis]].573 bytes (73 words) - 03:16, 7 October 2013
- {{r|Platelet activation}} {{r|Platelet aggregation inhibitor}}142 bytes (16 words) - 23:05, 17 February 2009
- {{r|Platelet activation}} {{r|Platelet aggregation inhibitors|Platelet aggregation inhibitor|**}}263 bytes (27 words) - 00:30, 3 March 2010
- #redirect [[Platelet]]22 bytes (2 words) - 15:23, 15 February 2007
- ...are deficient in or have a defect in the glycoprotein IIb-IIIa complex ([[Platelet glycoprotein GPIIb-IIIa complex]])."<ref name="MeSH-Thrombasthenia">{{MeSH}441 bytes (55 words) - 00:49, 14 September 2013
- #Redirect [[Platelet activation]]33 bytes (3 words) - 23:51, 29 April 2008
- #REDIRECT [[Platelet aggregation inhibitors]]45 bytes (4 words) - 08:13, 23 November 2010
- #REDIRECT [[Platelet aggregation inhibitors]]45 bytes (4 words) - 09:00, 23 November 2010
- #Redirect [[Platelet aggregation inhibitors]]45 bytes (4 words) - 23:50, 29 April 2008
- #redirect [[Platelet aggregation inhibitors]]45 bytes (4 words) - 09:48, 29 April 2008
- #REDIRECT [[Platelet aggregation inhibitors]]45 bytes (4 words) - 19:26, 16 October 2011
- #REDIRECT [[Platelet aggregation inhibitors]]45 bytes (4 words) - 15:21, 23 January 2014
- #REDIRECT [[Platelet glycoprotein GPIIb-IIIa complex]]54 bytes (5 words) - 08:28, 11 January 2008
- {{r|Platelet aggregation inhibitors|Platelet aggregation inhibitor}}215 bytes (22 words) - 17:24, 27 August 2008
- .../cgi/mesh/2008/MB_cgi?term=Platelet+Glycoprotein+GPIIb-IIIa+Complex |title=Platelet Glycoprotein GPIIb-IIIa Complex |accessdate=2008-01-10 |author=Anonymous |a ...irofiban]], block the platelet glycoprotein GPIIb-IIIa complex and inhibit platelet aggregation. They arp used to treat [[vascular disease]]s.2 KB (291 words) - 21:55, 14 February 2010
- {{r|Platelet activation}} {{r|Platelet aggregation inhibitors}}992 bytes (122 words) - 11:06, 11 January 2010
- A platelet aggregation inhibitor used to prevent cardiac events99 bytes (12 words) - 00:32, 16 March 2009
- Agents that antagonize or impair any mechanism leading to blood platelet aggregation.122 bytes (15 words) - 09:35, 8 September 2009
- Hemostasis consists of [[coagulation]] and [[platelet activation]]. For medical purposes, hemostasis can be inhibited by [[anticoagulant]]a or [[platelet aggregation inhibitor]]s.534 bytes (70 words) - 02:47, 7 October 2013
- Integrin receptor found on platelets for fibrinogen, and aids in platelet activation.122 bytes (15 words) - 09:37, 8 September 2009
- Auto-populated based on [[Special:WhatLinksHere/Platelet glycoprotein GPIIb-IIIa complex]]. Needs checking by a human. {{r|Platelet aggregation inhibitors}}562 bytes (68 words) - 19:35, 11 January 2010
- {{r|Platelet aggregation inhibitors}} {{r|Platelet}}638 bytes (80 words) - 11:56, 11 January 2010
- {{r|Platelet glycoprotein GPIIb-IIIa complex}} {{r|Platelet}}682 bytes (83 words) - 21:00, 11 January 2010
- ...)|plasma]]; the primary types being [[erythrocyte]]s, [[leukocyte]]s and [[platelet]]s176 bytes (23 words) - 13:02, 4 June 2010
- Auto-populated based on [[Special:WhatLinksHere/Platelet]]. Needs checking by a human. {{r|Platelet activation}}955 bytes (116 words) - 19:35, 11 January 2010
- ...[[Adenosine diphosphate|ADP]] or [[Adenosine triphosphate|ATP]] mediates [[platelet]] aggregation.232 bytes (26 words) - 10:54, 14 December 2009
- '''Platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit''' (or PAFAH1B250 bytes (34 words) - 08:53, 22 January 2009
- ...d components (or whole blood) such as [[erythrocyte]]s, [[leukocyte]]s, [[platelet]]s, and plasma from a donor to a recipient or back to the donor. Blood comp * [[Platelet transfusion]]998 bytes (129 words) - 05:35, 30 January 2011
- ...atelet]]s by fragmenting into small, odd-shaped pieces. These fragments ([[platelet]]s) of the megakaryocyte's [[cytoplasm]] circulate in the blood as the body ...its contents all at once in the marrow. Alternatively, the cell may form platelet ribbons into blood vessels. The ribbons are formed via psuedopodia and the2 KB (296 words) - 10:44, 10 June 2010
- {{r|Platelet}}195 bytes (22 words) - 15:14, 30 June 2009
- {{r|Platelet}}178 bytes (19 words) - 21:09, 10 December 2009
- {{r|Platelet activation}}151 bytes (16 words) - 17:22, 27 August 2008
- In [[pharmacology]], '''prasugrel''' is a [[platelet aggregation inhibitor]] of the [[thienopyridine]] class that blocks [[adeno406 bytes (38 words) - 17:36, 13 July 2011
- {{r|Platelet}}362 bytes (44 words) - 11:50, 15 February 2009
- ...' include [[eptifibatide]] and [[tirofiban]]. These medication block the [[platelet glycoprotein GPIIb-IIIa complex]] and are used for treating [[acute coronar671 bytes (85 words) - 10:09, 17 October 2010
- {{r|Platelet||**}}556 bytes (65 words) - 22:32, 2 June 2010
- ...d concentration, reduces incidence of cardiovascular disorders, prevents [[platelet aggregation]], and inhibits [[arachidonic acid]] conversion into the [[thro540 bytes (63 words) - 03:15, 7 October 2013
- {{r|Platelet glycoprotein GPIIb-IIIa complex}}469 bytes (58 words) - 16:53, 11 January 2010
- {{r|Platelet}}618 bytes (73 words) - 13:59, 26 November 2010
- ...nal |author=Fritz E, Ludwig H, Scheithauer W, Sinzinger H |title=Shortened platelet half-life in multiple myeloma |journal=Blood |volume=68 |issue=2 |pages=514 ...s Disease. The chronic form in adults is usually caused by antibodies to [[Platelet glycoprotein GPIIb-IIIa complex]] or Ib-IX.<ref name="isbn0-7216-0187-1"/>4 KB (579 words) - 13:26, 23 November 2010
- .../> This leaves vasoconstriction, platelet aggregation, and thrombosis from platelet thromboxane A2 mediated by COX-1 intact.<ref name="pmid-16968830"/>2 KB (265 words) - 09:16, 28 December 2010
- {{r|Platelet}}588 bytes (71 words) - 16:58, 11 January 2010
- {{r|Platelet}}619 bytes (80 words) - 21:25, 11 January 2010
- {{r|Platelet}}610 bytes (73 words) - 15:48, 11 January 2010
- {{r|Platelet}}651 bytes (80 words) - 10:59, 11 January 2010
- {{r|Platelet}}679 bytes (85 words) - 15:36, 11 January 2010
- ...actor complex. The von Willebrand factor has receptors for [[collagen]], [[platelet]]s, and [[ristocetin]] activity as well as the immunologically distinct ant629 bytes (86 words) - 17:31, 10 July 2010
- {{r|Platelet}}834 bytes (105 words) - 19:56, 11 January 2010
- {{r|Platelet}}759 bytes (101 words) - 15:55, 11 January 2010